Open Insider Trading Activity for Contineum Therapeutics, Inc. Chief Scientific Officer Lorrain Daniel S.
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction CTNM | 2026-06-01 | 2026-06-01 | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | 1 | 4,170 | $13.16 | $54,877.20 | 2.91% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction CTNM | 2026-05-01 | 2026-05-01 | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | 2 | 4,170 | $13.12 | $54,694.20 | 1.43% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction CTNM | 2026-04-06 | 2026-04-06 | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | 1 | 4,170 | $13.43 | $56,003.10 | 2.75% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction CTNM | 2026-03-02 | 2026-03-02 | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | 1 | 4,170 | $15.01 | $62,591.70 | 2.67% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction CTNM | 2026-02-26 | 2026-02-25 | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | 2 | 8,124 | $16.02 | $130,151.24 | 2.54% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction CTNM | 2026-02-13 | 2026-02-11 | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | 1 | 400 | $16.00 | $6,400.00 | 0.26% | View Filing |